Select Committee · Science and Technology Committee (Commons)

EU regulation of the life sciences inquiry

Status: Closed Opened: 21 Jan 2016 Closed: 3 May 2017 1 report
Inquiry scopeEU life sciences regulation—medicines and therapies, and biotechnologies—fosters cross-border research collaboration and allows UK science access to the EU market, the Science and Technology Committee has said in its report. The Government should be putting in place a contingency plan to protect our science sector in the event of a leave vote. Report: EU regulation of life sciences Report: EU regulation of life sciences (PDF 587.46 KB)

Reports

1 report

Oral evidence sessions

2 sessions

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date Session and witnesses Source
19 Apr 2016
Oral evidence session
No witnesses recorded
View ↗
22 Mar 2016
Oral evidence session
No witnesses recorded
View ↗

Correspondence

1 letter

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

PublishedDirectionLetter
2 Aug 2016 — EU regulation of the life sciences